Co-Diagnostics Inc (CODX) Stock Price, Quote & News

Company Profile

Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus...

Industry: Medical Devices

Sector: Healthcare

Phone: 801 438 1036

Website: co-dx.com

Address:

2401 S. Foothill Dr., Suite D, Salt Lake City, United States

Minutiae Jun. 5 at 1:26 AM

$CODX Is Co-Diagnostics National Security’s Next Diagnostic Pick? Jeffrey Neal Johnson - MarketBeat - Thu May 28, 10:00AM CDT https://www.theglobeandmail.com/investing/markets/stocks/CODX/pressreleases/2202358/is-co-diagnostics-national-securitys-next-diagnostic-pick/

0 · Reply

Stock_Catcher Jun. 5 at 1:19 AM

Fortune Friday Watchlist Pt.4 Looking for Flow $BULL $GNS $CODX $SOAR $SBEV

0 · Reply

looking4aprty Jun. 5 at 1:18 AM

$CODX QDEL went up today a lot today

0 · Reply

Ezflp1 Jun. 5 at 12:38 AM

$CODX

0 · Reply

Lizardbronsen Jun. 4 at 11:50 PM

$CODX buckle up! Here we go! 😁 😉 🚀

0 · Reply

Micro_Scanner Jun. 4 at 8:29 PM

$YYGH buckle up when retail catches wind of this, the float is about the size of $CODX and if you haven't seen how fast that thing runs, this will be the same. (both ways, expect wide swings).

0 · Reply

Great7 Jun. 4 at 8:23 PM

$CODX 430,000 shares👀

0 · Reply

FilthyPeasant Jun. 4 at 8:02 PM

$CODX Jane Street bought ~237k shares on 5/28/26. Filed 13-G today disclosing the ~6.5% stake. These shares were bought at far higher prices than today. No, they were not one of the two PIPE investors so these shares were bought anywhere between 8 and 13. We're down in the basement bargain bin still!

1 · Reply

Great7 Jun. 4 at 7:31 PM

$CODX Approximately one million shares were traded at $6 Only keeping 😀

0 · Reply

Great7 Jun. 4 at 7:30 PM

$CODX If it returns above $6 and closes there, we will see $12 in the coming days ✈️❤👍

0 · Reply

Co-Diagnostics announces continued progress in Ebola PCR development program

2026-06-02T14:07:28.000Z - 2 days ago

Co-Diagnostics trading halted, volatility trading pause

2026-06-02T13:54:50.000Z - 2 days ago

Co-Diagnostics trading resumes

Jun 2, 2026, 9:00 AM EDT - 2 days ago

Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities

2026-05-28T21:18:09.000Z - 7 days ago

Co-Diagnostics files to sell 4.94M shares of common stock for holders

May 28, 2026, 8:00 AM EDT - 7 days ago

Co-Diagnostics Registration statement: Registration filing

2026-05-27T15:15:44.000Z - 8 days ago

Co-Diagnostics trading halted, volatility trading pause

2026-05-27T15:08:07.000Z - 8 days ago

Co-Diagnostics trading resumes

2026-05-26T14:04:46.000Z - 9 days ago

Co-Diagnostics and CoSara Diagnostics advance with ebola PCR development

May 26, 2026, 9:00 AM EDT - 9 days ago

Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

May 19, 2026, 10:54 PM EDT - 15 days ago

Co-Diagnostics Announces $3.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules

2026-05-19T13:16:13.000Z - 16 days ago

Co-Diagnostics develops ebola assay strategy after recent global outbreak alert

May 19, 2026, 9:00 AM EDT - 16 days ago

Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

2026-05-14T21:49:36.000Z - 21 days ago

Co-Diagnostics reports Q1 EPS ($4.06) vs. ($7.05) last year

May 14, 2026, 4:30 PM EDT - 21 days ago

Co-Diagnostics Earnings Call Transcript: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

Co-Diagnostics Earnings release: Q1 2026

May 14, 2026, 4:30 PM EDT - 21 days ago

Co-Diagnostics Quarterly report: Q1 2026

May 14, 2026, 4:01 PM EDT - 21 days ago

Co-Diagnostics Reports First Quarter 2026 Financial Results

May 14, 2026, 4:00 PM EDT - 21 days ago

Co-Diagnostics Slides: Investor presentation

2026-05-12T20:55:31.000Z - 23 days ago

Co-Diagnostics files $150M mixed securities shelf

May 12, 2026, 8:00 AM EDT - 23 days ago

Co-Diagnostics Registration statement: Registration filing

2026-05-08T15:28:11.000Z - 27 days ago

Co-Diagnostics’ joint venture with CoMira finalizes facility lease agreement

May 8, 2026, 9:00 AM EDT - 27 days ago

Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City

Apr 30, 2026, 9:00 AM EDT - 5 weeks ago

Co-Diagnostics Announces First Quarter 2026 Earnings Release Date and Webcast

Apr 16, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.

Apr 14, 2026, 9:00 AM EDT - 7 weeks ago

Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Apr 9, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah

Mar 31, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Earnings Call Transcript: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Annual report: Q4 2025

Mar 31, 2026, 4:30 PM EDT - 2 months ago

Co-Diagnostics Earnings release: Q4 2025

Mar 31, 2026, 4:01 PM EDT - 2 months ago

Co-Diagnostics Reports Full Year 2025 Financial Results

Mar 25, 2026, 8:00 AM EDT - 2 months ago

Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization

2026-03-20T12:11:57.000Z - 2 months ago

Co-Diagnostics to expand commercial, distribution territory across South Asia

Mar 20, 2026, 8:00 AM EDT - 2 months ago

Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia

Mar 17, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Webcast

Mar 16, 2026, 9:00 AM EDT - 2 months ago

Co-Diagnostics to Present at Medical Korea 2026

Mar 12, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Receives Japanese Patent Covering Co-Dx PCR Platform Technologies

Mar 10, 2026, 9:00 AM EDT - 3 months ago

Co-Diagnostics Regains Compliance with Nasdaq Listing Requirements

Feb 9, 2026, 9:00 AM EST - 4 months ago

Co-Diagnostics to Showcase PCR Platform at World Health Expo Labs Dubai

Feb 5, 2026, 9:00 AM EST - 4 months ago

Co-Diagnostics Joint Venture CoSara Receives CDSCO License to Manufacture and Sell CoSara PCR Pro™ Instrument

Feb 4, 2026, 9:00 AM EST - 4 months ago

Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform

2026-01-23T14:10:52.000Z - 4 months ago

Co-Diagnostics cut to Hold at Maxim on Nasdaq delisting

2026-01-23T13:00:47.000Z - 4 months ago

Co-Diagnostics downgraded to Hold from Buy at Maxim

2026-01-13T17:30:17.000Z - 5 months ago

Co-Diagnostics trading resumes

Jan 12, 2026, 9:00 AM EST - 5 months ago

Co-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships

Dec 30, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics Announces Reverse Stock Split

Dec 29, 2025, 9:00 AM EST - 5 months ago

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

Dec 18, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India

Dec 17, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Dec 9, 2025, 9:00 AM EST - 6 months ago

Co-Diagnostics to Present on Co-Dx™ PCR Platform and AI Integration at Point-of-Care Testing 2025

Dec 8, 2025, 12:36 PM EST - 6 months ago

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Nov 20, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health

Nov 18, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 7 months ago

Co-Diagnostics Earnings release: Q3 2025

Nov 13, 2025, 4:01 PM EST - 7 months ago

Co-Diagnostics Reports Third Quarter 2025 Financial Results

Nov 10, 2025, 7:00 AM EST - 7 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Nov 5, 2025, 11:00 AM EST - 7 months ago

Co-Diagnostics Transcript: Fireside Chat

Nov 5, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd

Nov 3, 2025, 9:00 AM EST - 7 months ago

Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform

Oct 31, 2025, 9:00 AM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Oct 31, 2025, 8:00 AM EDT - 7 months ago

Co-Diagnostics Proxy statement: Proxy Filing

Oct 30, 2025, 1:57 PM EDT - 7 months ago

Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia

Oct 29, 2025, 12:51 PM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 28, 2025, 9:33 AM EDT - 7 months ago

Co-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 22, 2025, 8:30 AM EDT - 8 months ago

Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia

Oct 16, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing

Oct 13, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit

Sep 30, 2025, 4:15 PM EDT - 8 months ago

Co-Diagnostics Transcript: Lytham Partners Fall 2025 Investor Conference

Sep 30, 2025, 9:30 AM EDT - 8 months ago

Co-Diagnostics, Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30

Sep 18, 2025, 5:05 PM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 17, 2025, 9:47 AM EDT - 9 months ago

Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Sep 11, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. Performs Analysis of Chikungunya Co-Primers® to Confirm Reactivity Against Known Virus Strains

Sep 9, 2025, 9:30 AM EDT - 9 months ago

Co-Diagnostics, Inc. Honored at Utah Business 2025 Innovation Awards Summit

Aug 18, 2025, 9:30 AM EDT - 10 months ago

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Co-Diagnostics Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Co-Diagnostics Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 10 months ago

Co-Diagnostics Earnings release: Q2 2025

Aug 14, 2025, 4:01 PM EDT - 10 months ago

Co-Diagnostics, Inc. Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast

Jul 15, 2025, 9:30 AM EDT - 11 months ago

Co-Diagnostics, Inc. to Host Booth at WHX Kuala Lumpur on July 16-18, 2025

May 14, 2025, 9:30 AM EDT - 1 year ago

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Co-Diagnostics Earnings release: Q1 2025

May 8, 2025, 4:01 PM EDT - 1 year ago

Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results

Minutiae Jun. 5 at 1:26 AM

0 · Reply

Stock_Catcher Jun. 5 at 1:19 AM

Fortune Friday Watchlist Pt.4 Looking for Flow $BULL $GNS $CODX $SOAR $SBEV

0 · Reply

looking4aprty Jun. 5 at 1:18 AM

$CODX QDEL went up today a lot today

0 · Reply

Ezflp1 Jun. 5 at 12:38 AM

$CODX

0 · Reply

Lizardbronsen Jun. 4 at 11:50 PM

$CODX buckle up! Here we go! 😁 😉 🚀

0 · Reply

Micro_Scanner Jun. 4 at 8:29 PM

$YYGH buckle up when retail catches wind of this, the float is about the size of $CODX and if you haven't seen how fast that thing runs, this will be the same. (both ways, expect wide swings).

0 · Reply

Great7 Jun. 4 at 8:23 PM

$CODX 430,000 shares👀

0 · Reply

FilthyPeasant Jun. 4 at 8:02 PM

1 · Reply

Great7 Jun. 4 at 7:31 PM

$CODX Approximately one million shares were traded at $6 Only keeping 😀

0 · Reply

Great7 Jun. 4 at 7:30 PM

$CODX If it returns above $6 and closes there, we will see $12 in the coming days ✈️❤👍

0 · Reply

Lizardbronsen Jun. 4 at 6:22 PM

$CODX thank for heads up. XLV is a healthcare sector. Does that help too?

0 · Reply

NYChichas Jun. 4 at 5:52 PM

$CODX XBI bounce = the whole sector goes up

0 · Reply

PharmGal Jun. 4 at 5:50 PM

$AIM Webinar this am: AIM has FDA and EMA(EU fda) approval for Orphan Drug Status in treating Ebola. They have just reached out to the WHO with already-published data showing treatment with Ampligen followed by ebola exposure in rats, led to 100% survival.(you can't study this in humans as it's too deadly) Has implications for pretreating healthcare workers, exposed family members, and exposed villages. Most details start around 18:00 in this webinar: Good for $CODX and $AEMD folks to know, too. https://virtualinvestorco.com/aim/

1 · Reply

Bank_of_Gotham Jun. 4 at 5:46 PM

$CODX Nice 30%

0 · Reply

coolmate25 Jun. 4 at 5:33 PM

$CODX Not bad ! It's fine for today with market still not that good because of middle east crisis. Pray for war to be over and wish for bull run next week .

0 · Reply

TradingTipsMaster Jun. 4 at 5:32 PM

$CODX 9 possible today

0 · Reply